Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hip resurfacing device under Long-Term study

NCT ID NCT06775704

First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 33 times

Summary

This observational study will follow 150 people aged 18 to 65 with hip arthritis or hip dysplasia who receive the ROMAX hip resurfacing system. Researchers will track how long the implant lasts and measure hip function and patient satisfaction over 10 years. The goal is to confirm the device's safety and performance in real-world use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS HIP are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier Universitaire de Lille

    RECRUITING

    Lille, 59000, France

Conditions

The condition(s) this trial relates to.

arthritic joint disease Hip Dislocation, Congenital

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.